rs140516942

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_052918.5(SORCS1):​c.1526C>T​(p.Thr509Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00184 in 1,613,958 control chromosomes in the GnomAD database, including 49 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T509K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0088 ( 28 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 21 hom. )

Consequence

SORCS1
NM_052918.5 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.73
Variant links:
Genes affected
SORCS1 (HGNC:16697): (sortilin related VPS10 domain containing receptor 1) This gene encodes one family member of vacuolar protein sorting 10 (VPS10) domain-containing receptor proteins. The VPS10 domain name comes from the yeast carboxypeptidase Y sorting receptor Vps10 protein. Members of this gene family are large with many exons but the CDS lengths are usually less than 3700 nt. Very large introns typically separate the exons encoding the VPS10 domain; the remaining exons are separated by much smaller-sized introns. These genes are strongly expressed in the central nervous system. Two of the five family members (sortilin and sortilin-related receptor) are synthesized as preproproteins; it is not yet known if this encoded protein is also a preproprotein. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036620796).
BP6
Variant 10-106688226-G-A is Benign according to our data. Variant chr10-106688226-G-A is described in ClinVar as [Benign]. Clinvar id is 784167.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00877 (1335/152288) while in subpopulation AFR AF = 0.0309 (1282/41546). AF 95% confidence interval is 0.0295. There are 28 homozygotes in GnomAd4. There are 640 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 28 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SORCS1NM_052918.5 linkc.1526C>T p.Thr509Met missense_variant Exon 10 of 26 ENST00000263054.11 NP_443150.3 Q8WY21-1B3KWN9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SORCS1ENST00000263054.11 linkc.1526C>T p.Thr509Met missense_variant Exon 10 of 26 1 NM_052918.5 ENSP00000263054.5 Q8WY21-1
SORCS1ENST00000369698.6 linkc.257C>T p.Thr86Met missense_variant Exon 2 of 19 5 ENSP00000358712.2 X6R7D6

Frequencies

GnomAD3 genomes
AF:
0.00878
AC:
1336
AN:
152170
Hom.:
28
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0310
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00242
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00259
AC:
650
AN:
251068
AF XY:
0.00184
show subpopulations
Gnomad AFR exome
AF:
0.0332
Gnomad AMR exome
AF:
0.00203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000185
Gnomad OTH exome
AF:
0.00131
GnomAD4 exome
AF:
0.00112
AC:
1636
AN:
1461670
Hom.:
21
Cov.:
31
AF XY:
0.000945
AC XY:
687
AN XY:
727130
show subpopulations
African (AFR)
AF:
0.0351
AC:
1173
AN:
33464
American (AMR)
AF:
0.00221
AC:
99
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.000176
AC:
7
AN:
39688
South Asian (SAS)
AF:
0.000243
AC:
21
AN:
86244
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00503
AC:
29
AN:
5764
European-Non Finnish (NFE)
AF:
0.000113
AC:
126
AN:
1111878
Other (OTH)
AF:
0.00300
AC:
181
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
82
163
245
326
408
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00877
AC:
1335
AN:
152288
Hom.:
28
Cov.:
33
AF XY:
0.00860
AC XY:
640
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0309
AC:
1282
AN:
41546
American (AMR)
AF:
0.00242
AC:
37
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5180
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68024
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
68
136
205
273
341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00323
Hom.:
14
Bravo
AF:
0.0102
ESP6500AA
AF:
0.0322
AC:
142
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00315
AC:
382
EpiCase
AF:
0.000164
EpiControl
AF:
0.000238

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 12, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
23
DANN
Benign
0.97
DEOGEN2
Benign
0.16
T;.;T;.;.
Eigen
Benign
0.18
Eigen_PC
Uncertain
0.30
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.71
T;T;T;T;T
MetaRNN
Benign
0.0037
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L;.;.;.;.
PhyloP100
2.7
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.4
N;.;.;N;.
REVEL
Benign
0.12
Sift
Benign
0.17
T;.;.;T;.
Sift4G
Benign
0.20
T;T;T;T;T
Polyphen
0.20
B;.;.;.;.
Vest4
0.26
MVP
0.10
MPC
0.28
ClinPred
0.020
T
GERP RS
6.2
Varity_R
0.061
gMVP
0.67
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140516942; hg19: chr10-108447984; API